Non-Hispanic White men the most likely to report having used the product
TUESDAY, Sept. 16, 2025 (HealthDay News) — The percentage of U.S. adults using nicotine pouches remains low, according to a research letter published online Sept. 8 in JAMA Network Open.
Cristine D. Delnevo, Ph.D., M.P.H., from Rutgers University in New Brunswick, New Jersey, and colleagues used data from the 2022 to 2023 Tobacco Use Supplement to the Current Population Survey to better understand nicotine pouch use among adults. The analysis included data from 110,084 adult self-respondents.
The researchers found that the prevalence of ever (weighted percentage, 2.65 percent), current (weighted percentage, 0.42 percent), and daily (weighted percentage, 0.18 percent) use of nicotine pouches was low. A significantly higher prevalence was seen for adults who were male and non-Hispanic White. Among tobacco-naive adults, ever, current, and daily use was virtually nonexistent. Current and daily use of nicotine pouches was highest among adults who recently quit another product.
“Our results suggest that adults may be using nicotine pouches for harm reduction given that use is highest among those that have recently quit another tobacco product or e-cigarettes,” Delnevo said in a statement. “We should always keep a watchful eye on youth tobacco-use behaviors, including use of multiple products, substitution with other products, or alternative methods of finding and using flavored tobacco and nicotine products.”
One author reported serving as a special government employee (chair of the U.S. Food and Drug Administration Tobacco Product Scientific Advisory Board) outside the submitted work.
Frequent TV Watching Linked to Smaller Brain Volume
Greater Physician Knowledge Linked to Lower Use of Low-Value Services
2018 to 2024 Saw Rise in Insurance Denials for Brand-Name Drugs
Tobacco Treatment Program Effective in Oncology Settings
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
Few Young Adults Receive Palliative Care as Part of Advanced Cancer Treatment
Emergency Presentation of Cancer Common in Older Adults